NCT00156325View on ClinicalTrials.gov

Escitalopram as a Mood Stabilizer for Bipolar II Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

February 28, 2005

Conditions
Bipolar Disorders
Interventions
DRUG

Escitalopram (Lexapro)

Trial Locations (1)

2031

University of New South Wales, Sydney

All Listed Sponsors
lead

The University of New South Wales

OTHER

NCT00156325 - Escitalopram as a Mood Stabilizer for Bipolar II Disorder | Biotech Hunter | Biotech Hunter